NCT05189041

Brief Summary

Stroke is the leading cause of disability in France with 130,000 cases per year, 20% of strokes being hemorrhagic, with a majority of intracranial aneurysm rupture (80%). Each year, 6000 meningeal hemorrhages (MHA) caused by cerebral aneurysm rupture are reported in France: 40% of patients die within the first month and 30% are left with severe and permanent disability. Intracranial aneurysms are present in 2 to 6% of the population and only about 0.5% of them will rupture. Given the human and economic costs associated with this disease, systematic medical screening for intracranial aneurysms could be useful. However, the operative risk of endovascular treatment remains non-zero (around 1%) and could be proposed only to a selected population of aneurysms at risk of rupture. The absence of diagnostic criteria for aneurysmal vulnerability does not allow for the moment to consider screening for this disease, which continues to strike without warning a young and active population. Nevertheless, access to brain imaging allows the detection of an increasing number of intracranial aneurysms. The question of preventive treatment then arises and is still a difficult point discussed by neurosurgeons / neurointerventionists based on general epidemiological data difficult to apply to an individual.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
4.1 years until next milestone

First Submitted

Initial submission to the registry

December 27, 2021

Completed
16 days until next milestone

First Posted

Study publicly available on registry

January 12, 2022

Completed
Last Updated

January 12, 2022

Status Verified

December 1, 2021

Enrollment Period

3.5 years

First QC Date

December 27, 2021

Last Update Submit

January 11, 2022

Conditions

Keywords

aneurysm

Outcome Measures

Primary Outcomes (1)

  • Quantify the aneurysmal pulsation in functional MRI

    Quantify the aneurysmal pulsation in functional MRI on the patient with Ruptured Cerebral Aneurysm or Non ruptured Aneurysm

    1 day

Study Arms (2)

Ruptured Cerebral Aneurysm

OTHER

Quantify the aneurysmal pulsation in functional MRI on the patient with Ruptured Cerebral Aneurysm

Other: Aneurysmal pulsation in functional MRI

Non Ruptured Cerebral Aneurysm

OTHER

Quantify the aneurysmal pulsation in functional MRI on the patient with Non Ruptured Cerebral Aneurysm

Other: Aneurysmal pulsation in functional MRI

Interventions

Quantify the aneurysmal pulsation in functional MRI on the patient with Ruptured Cerebral Aneurysm

Non Ruptured Cerebral AneurysmRuptured Cerebral Aneurysm

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age limits to \> 18 years
  • Collection of the informed consent (patient or legal representant)
  • Affiliation or recipient with the mode of social security
  • \- Groupe anévrysme rompu
  • Patient porteur d'un anévrysme rompu
  • \- Groupe anévrysme non rompu
  • Patient porteur d'un anévrysme non rompu

You may not qualify if:

  • Subject presenting contraindications in MRI (Ferromagnetic foreign bodies, pace-maker …)
  • Claustrophobia
  • Women pregnant or Breast-feeding
  • Patient participating in an other study
  • Person with majority age protected by the law (supervision or trusteeship).
  • Patient not reading the french language
  • Patient or representant for whom it impossible to give accurate informations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

COSTALAT

Montpellier, 34295, France

Location

MeSH Terms

Conditions

Aneurysm

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • VINCENT COSTALAT

    University Hospital, Montpellier

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 27, 2021

First Posted

January 12, 2022

Study Start

June 1, 2014

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

January 12, 2022

Record last verified: 2021-12

Locations